Neutron First Flight Still the Linchpin as Backlog Hits $2.4B

What happened

Rocket Lab's backlog has reached $2.4 billion, confirming the growth trajectory already disclosed in the recent 10-Q, but the new Motley Fool article offers no fresh operational data. The article correctly emphasizes that Neutron's first flight matters more than the backlog headline because a portion of that backlog is contingent on Neutron reaching the pad in Q4 2026. However, management provided no specific launch date, consistent with the 10-Q language that the window for an end-of-year launch is narrowing. This reiteration does not alter the fundamental valuation picture: the stock at $80 already prices in a timely Neutron debut and manageable Iridium financing. Consequently, we maintain our WAIT rating with no change to fair value estimates.

Implication

The $2.4B backlog is a positive signal but was already reflected in our analysis, so it does not shift valuation. The absence of a firm Neutron launch date keeps schedule risk elevated, and investors should watch for completion of first-stage qualification and any narrowing of the launch window. Iridium financing remains a key overhang, with potential dilution if permanent capital is not secured before the bridge matures. Until these binary catalysts resolve, risk/reward at $80 is balanced, favoring a hold. Our re-assessment window remains 3-6 months, with triggers at $65 attractive entry and $95 trim above.

Thesis delta

The article provides no new information beyond the 10-Q already analyzed. The backlog figure is slightly higher due to rounding but does not alter revenue or margin assumptions. The core thesis remains unchanged: WAIT, pending proof points on Neutron timing and Iridium financing.